Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of General Virology|October 24, 2003
Retrovirus vector production and transduction: modulation by the cell cycleAlla Dolnikov, Simon Wotherspoon, Michelle Millington, et al.
Plos One|August 4, 2009
Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cellsMichelle Millington, Allison Arndt, Maureen Boyd, et al.
Viruses|July 31, 2015
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral EscapeGero Hütter, Josef Bodor, Scott Ledger, et al.
Cancer Gene Therapy|September 23, 2003
A sensitive dual-fluorescence reporter system enables positive selection of ras suppressors by suppression of ras-induced apoptosisAlla Dolnikov, Sylvie Shen, Michelle Millington, et al.
Experimental Hematology|September 4, 2004
Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouseSylvie W Shen, Alla Dolnikov, Toby Passioura, et al.
The Journal of Gene Medicine|March 20, 2018
Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46Scott Ledger, Annett Howe, Stuart Turville, et al.
Molecular Therapy. Nucleic Acids|December 5, 2013
Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene SilencingKazuo Suzuki, Shinichiro Hattori, Katherine Marks, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitorOrit Wolstein, Maureen Boyd, Michelle Millington, et al.
Pageof 1